Vitenskapelig artikkel
-
Kjetil Vikene; Geir Olve Skeie; Karsten Specht
(2019). Compensatory task-specific hypersensitivity in bilateral planum temporale and right superior temporal gyrus during auditory rhythm and omission processing in Parkinson?s disease. (ekstern lenke)
-
Christian Amdahl; Espen Homleid Alseth; Nils Erik Gilhus
et al. (2007). Polygenic disease associations in thymomatous myasthenia gravis. (ekstern lenke)
-
Yu Hong; Geir Olve Skeie; Paraskevi Zisimopoulou
et al. (2017). Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli
et al. (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. (ekstern lenke)
-
Yu Hong; Hai-Feng Li; Fredrik Robert Romi
et al. (2018). HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. (ekstern lenke)
-
Steven Paul Luckman; Geir Olve Skeie; Geir Helgeland
et al. (2006). Morphological effects of myasthenia gravis patient sera on human muscle cells. (ekstern lenke)
-
Maziar Behbahani; Geir Olve Skeie; Geir Egil Eide
et al. (2019). A prospective study of the natural history of incidental meningioma-Hold your horses!. (ekstern lenke)
-
Geir Olve Skeie; Alexandra Freburg; G Kolmerer
et al. (1997). Titin transcript in thymomas. (ekstern lenke)
-
Geir Olve Skeie; Fredrik Romi; Johan Arild Aarli
et al. (2003). Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. (ekstern lenke)
-
Ole Tveiten; Geir Olve Skeie; Kristoffer Haugarvoll
et al. (2013). Treatment in early Parkinson's disease: the Norwegian ParkWest study. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli
et al. (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli
et al. (2000). Muscle autoantibodies in subgroups of myasthenia gravis patients. (ekstern lenke)
-
E Lübke; A Freiburg; Geir Olve Skeie
et al. (1998). Striational autoantibodies in myasthenia gravis patients recognizw I-band titin epitopes. (ekstern lenke)
-
Bernd Mueller; Jan Petter Larsen; Tore Wentzel-Larsen
et al. (2011). Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s Disease : frequent but mild. (ekstern lenke)
-
Geir Olve Skeie; Slobodanka Apostolski; Amelia Evoli
et al. (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. (ekstern lenke)
-
Geir Olve Skeie; Johan Arild Aarli; Nils Erik Gilhus
(2006). Titin and ryanodine receptor antibodies in myasthenia gravis. (ekstern lenke)
-
Yu Hong; Hai-Feng Li; Geir Olve Skeie
et al. (2016). Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients. (ekstern lenke)
-
Geir Olve Skeie; Bernd Mueller; Kristoffer Haugarvoll
et al. (2010). Differential Effect of Environmental Risk Factors on Postural Instability Gait Difficulties and Tremor Dominant Parkinson's Disease. (ekstern lenke)
-
Geir Olve Skeie; PK Lunde; OM Sejersted
et al. (1998). Myasthenia gravis sera containing anti-ryanodine receptor antibodies inhibit binding of (3H-) ryanodine to sarcoplasmic reticulum. (ekstern lenke)
-
Geir Olve Skeie; PK Lunde; OM Sejersted
et al. (1998). Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. (ekstern lenke)
-
SP Luckman; Geir Olve Skeie; G Helgeland
et al. (2004). Cytoxic Effects of Myasthenia Gravis Patient Sera on Primary Human Skeletal Muscle Cell Cultures. (ekstern lenke)
-
Johan Arild Aarli; Nils Erik Gilhus; Fredrik R. Romi
et al. (2009). Myasthenia gravis in the elderly. (ekstern lenke)
-
Geir Olve Skeie; JP Pandey; Johan Arild Aarli
et al. (1999). TNFB polymorphisms in myasthenia gravis. (ekstern lenke)
-
Simon Ulvenes Kverneng; Sepideh Mostafavi; Yana Mikhaleva
et al. (2025). Platelet mitochondrial complex I and IV activities are not reliable stratification biomarkers in Parkinson's disease. (ekstern lenke)
-
Geir Olve Skeie; Bente Müller; Kristoffer Haugarvoll
et al. (2013). Parkinson disease: Associated disorders in the Norwegian population based incident ParkWest study. (ekstern lenke)
-
Geir Olve Skeie
(2000). Skeletal muscle titin: physiology and pathophysiology. (ekstern lenke)
-
Hanne Marie Bøe Lunde; Geir Olve Skeie; Anne Kjørsvik
et al. (2012). Focal myositis - A neurogenic phenomenon?. (ekstern lenke)
-
Bente Skeie; Geir Olve Skeie; Per Øyvind Enger
et al. (2011). Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. (ekstern lenke)
-
Kjetil Vikene; Geir Olve Skeie; Karsten Specht
(2019). Subjective judgments of rhythmic complexity in Parkinson's disease: Higher baseline, preserved relative ability, and modulated by tempo. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler
et al. (2000). Complement activation by titin and ryanoidine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
-
Nils Erik Gilhus; Geir Olve Skeie; Fredrik Robert Romi
et al. (2011). Myasthenia gravis autoantibodies have a target also outside the neuromuscular junction. (ekstern lenke)
-
Johannes Jernqvist Gaare; Geir Olve Skeie; Charalampos Tzoulis
et al. (2017). Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. (ekstern lenke)
-
Ivar Otto Gjerde; Anette Storstein; Geir Olve Skeie
et al. (1998). Ataksi på grunn av vitamin E-mangel. (ekstern lenke)
-
Andreas O. Myking; Geir Olve Skeie; JE Varhaug
et al. (1998). The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. (ekstern lenke)
-
Fredrik Romi; Lars Bø; Geir Olve Skeie
et al. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. (ekstern lenke)
-
Håvard Torvik Gotaas; Geir Olve Skeie; Nils Erik Gilhus
(2016). Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap. (ekstern lenke)
-
Kjetil Vikene; Geir Olve Skeie; Karsten Specht
(2018). Abnormal phasic activity in saliency network, motor areas, and basal ganglia in Parkinson's disease during rhythm perception. (ekstern lenke)
-
Geir Olve Skeie; Per K. Lunde; Ole M. Sejersted
et al. (2001). Autoimmunity against the ryanodine receptor in myasthenia gravis. (ekstern lenke)
-
Berit Vik; Geir Olve Skeie; Eirik Vikane
et al. (2018). Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury. (ekstern lenke)
-
Espen Homleid Alseth; Hanne Linda Nakkestad; Jan Harald Aarseth
et al. (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. (ekstern lenke)
-
Sander Johan Aarli; Tarek Mazzawi; Geir Olve Skeie
(2015). En kvinne med kraftsvikt i armer og bein. (ekstern lenke)
-
Geir Olve Skeie; Åse Mygland; S Treves
et al. (2003). Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. (ekstern lenke)
-
Halvor Næss; Liv Hammersvik; Geir Olve Skeie
(2009). Aphasia among Young Patients with Ischemic Stroke on Long-term Follow-up. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Christian A. Vedeler
et al. (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. (ekstern lenke)
-
Bente Skeie; Geir Olve Skeie; Per Øyvind Enger
et al. (2011). Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. (ekstern lenke)
-
Espen Homleid Alseth; Angelina Maniaol; Ahmed Elsais
et al. (2011). Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. (ekstern lenke)
-
Nils Erik Gilhus; Jone Furulund Owe; Jana Midelfart Hoff
et al. (2011). Myasthenia gravis; a review of available treatment approaches. (ekstern lenke)
-
Hai-Feng Li; Yu Hong; Xu Zhang
et al. (2016). Gene polymorphisms for both auto-antigen and immune-modulating proteins are associated with the susceptibility of autoimmune myasthenia gravis. (ekstern lenke)
-
Geir Olve Skeie
(2000). Skeletal muscle titin: physiology and pathophysiology. (ekstern lenke)
-
Geir Olve Skeie; Johan Arild Aarli; Roald Matre
et al. (1997). Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. (ekstern lenke)
-
Geir Olve Skeie; JP Pandey; Johan Arild Aarli
et al. (1997). Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. (ekstern lenke)
-
Ketil K Sund; Geir Olve Skeie; Nils Erik Gilhus
et al. (1997). Diagnostikk av thymom og thymusatrofi hos pasienter med myasthenia gravis. (ekstern lenke)
-
Cochavit Elefant; Felicity A. Baker; Meir Lotan
et al. (2012). The Effect of Group Music Therapy on Mood, Speech, and Singing in Individuals with Parkinson's Disease - A Feasibility Study. (ekstern lenke)
-
Brage Brakedal; Ole-Bjørn Tysnes; Geir Olve Skeie
et al. (2014). The factor structure of the UPDRS motor scores changes during early Parkinson's disease. (ekstern lenke)
-
Guttorm Raknes; Geir Olve Skeie; Nils Erik Gilhus
et al. (1998). FcgRIIA and RIIIB polymorphisms in myasthenia gravis. (ekstern lenke)
-
Geir Olve Skeie; PT Bentsen; A Freiburg
et al. (1998). Cell-mediated immune response against titin in myasthenia gravis; evidence for the involvment of Th1 and Th2 cells. (ekstern lenke)
-
Nils Erik Gilhus; Fredrik Robert Romi; Yu Hong
et al. (2018). Myasthenia gravis and infectious disease. (ekstern lenke)
-
Yu Hong; Paraskevi Zisimopoulou; Nikolaos B. Trakas
et al. (2017). Multiple antibody detection in `seronegative? myasthenia gravis patients. (ekstern lenke)
-
Geir Olve Skeie; Slobodanka Apostolski; Amelia Evoli
et al. (2006). Guidelines for the treatment of autoimmune neuromuscular transmission disorders. (ekstern lenke)
-
Haakon Berven; Simon Ulvenes Kverneng; Erika Sheard
et al. (2023). NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. (ekstern lenke)
-
Irene Hana Flønes; Erika Fernandez-Vizarra; Maria Lykouri
et al. (2017). Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. (ekstern lenke)
-
Johan Arild Aarli; Geir Olve Skeie; Åse Mygland
et al. (1998). Muscle striation antibodies in myasthenia gravis; diagnostic and functional significance. (ekstern lenke)
-
Per Øyvind Enger; Geir Olve Skeie; Frits Alan Thorsen
et al. (2010). Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. (ekstern lenke)
-
Johan Arild Aarli; Nils Erik Gilhus; Fredrik Romi
et al. (2008). Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. (ekstern lenke)
-
Sidsel Marit Bragstad; Marianne Flatebø; Gerd Karin Natvig
et al. (2018). Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. (ekstern lenke)
-
Brage Brakedal; Christian Dölle; Frank Riemer
et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (ekstern lenke)
-
Fredrik Romi; Nils Erik Gilhus; Jan Erik Varhaug
et al. (2002). Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. (ekstern lenke)
-
Fredrik Romi; Geir Olve Skeie; Johan Arild Aarli
et al. (2000). The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. (ekstern lenke)
-
Steven Paul Luckman; Geir Olve Skeie; Geir Helgeland
et al. (2006). Effects of myasthenia gravis patient sera on human myoblast cultures. (ekstern lenke)
-
Geir Olve Skeie; A Freiburg; B Kolmerer
et al. (1998). Titin transcripts in thymoma. (ekstern lenke)
-
Bente Sandvei Skeie; Per Øyvind Enger; Jonathan Knisely
et al. (2020). A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. (ekstern lenke)
-
Simon Ulvenes Kverneng; Kjersti Eline Stige; Haakon Berven
et al. (2025). Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease. (ekstern lenke)
-
Sissel Evy Monstad; Lars Drivsholm; Geir Olve Skeie
et al. (2008). CRMP5 antibodies in patients with small-cell lung cancer or thymoma. (ekstern lenke)
-
Fredrik Romi; Nils Erik Gilhus; Jan Erik Varhaug
et al. (2003). Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. (ekstern lenke)
-
Bente Sandvei Skeie; Per Øyvind Enger; Jeremy Christopher Ganz
et al. (2013). Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. (ekstern lenke)
-
Johan Arild Aarli; Fredrik Romi; Geir Olve Skeie
et al. (2003). Myasthenia gravis in individuals over forty. (ekstern lenke)
-
Kristian Varden Gjerde; Bernd Mueller; Geir Olve Skeie
et al. (2018). Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease. (ekstern lenke)
-
Berit Vik; Geir Olve Skeie; Karsten Specht
(2019). Neuroplastic effects in patients with traumatic brain injury after music-supported therapy. (ekstern lenke)
-
Cochavit Elefant; Meir Lotan; Felicity A. Baker
et al. (2012). Effects of music therapy on facial expression of individuals with Parkinson's disease: A pilot study. (ekstern lenke)
-
Torbjørn Austveg Strømsnes; Morten Lund-Johansen; Geir Olve Skeie
et al. (2023). Growth dynamics of incidental meningiomas: A prospective long-term follow-up study. (ekstern lenke)
-
Bernd Mueller; J. Assmus; J. P. Larsen
et al. (2013). Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease. (ekstern lenke)
Medieintervju
Deltakelse i radio eller TV
Doktorgradsavhandling
Konferanseabstrakt
Konferanseposter
Konferanseforedrag
Vitenskapelig bokkapittel
Vitenskapelig litteraturgjennomgang
Populærvitenskapelig artikkel
Rettelse i tidsskrift
Se en full oversikt over publikasjoner i Cristin